MSTN mRNA was markedly overexpressed in DN in the glomeruli and tubulointerstitium (a ~20 to 40-fold increase vs. controls, and a ~4 to 8-fold increase vs. glomerular diseases, respectively, p < 0–05–0.01). Here, MSTN is linked to liver dysplastic nodule.